Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis

Abstract

Aim: Resistance to hormonal and targeted therapies in breast cancer limits treatment efficacy. Epigenetic alterations, including changes mediated by DNA methyltransferases, play a key role in this process. Previously, we identified that resistance to tamoxifen and rapamycin is associated with the suppression of DNMT3A. This study aims to further explore the mechanisms underlying this suppression, with a focus on identifying NR6A1 as a novel regulatory factor.

Methods: Acquisition of resistant breast cancer cell sublines, MTT-test, immunoblotting, transient transfection and reporter analysis, lentiviral infection, qRT-PCR, and analysis of methylation using bisulfite pyrosequencing.

Results: Our findings indicate that the development of cross-resistance in breast cancer cells to hormonal and targeted therapies involves a shift in cell signaling to alternative AKT pathways, marked by a localized suppression of the NR6A1/DNMT3A axis and associated DNA methylation changes. We demonstrated the critical role of NR6A1 downregulation in resistance development. Additionally, we observed activation of Snail - a key regulator in the epithelial-mesenchymal transition - as a mediator of the effects of NR6A1 depletion, establishing a direct link between Snail expression and resistance formation.

Conclusion: The coordinated suppression of NR6A1 and DNMT3A may contribute to sustaining the resistant phenotype in breast cancer cells. This pathway could serve as a predictive marker, helping guide the selection of optimal therapeutic strategies for breast cancer treatment in the future.

Keywords

Breast cancer / tamoxifen / rapamycin / methylation / DNMT3A / NR6A1 / Snail / estrogen receptor α / MCF-7 cells

References

[1] Bijnsdorp IV.Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro.Cancer Drug Resist2021;4:719-27 PMCID:PMC9094079

[2] Boichuk S,Galembikova A.Fibroblast growth factor 2 (FGF2) activates vascular endothelial growth factor (VEGF) signaling in gastrointestinal stromal tumors (GIST): an autocrine mechanism contributing to imatinib mesylate (IM) resistance.Cancers2024;16:3103 PMCID:PMC11394061

[3] Dugina V,Khromova N.Imbalance between actin isoforms contributes to tumour progression in taxol-resistant triple-negative breast cancer cells.Int J Mol Sci2024;25:4530 PMCID:PMC11049934

[4] Scherbakov AM,Sorokin DV.Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance.Cancer Drug Resist2023;6:103-15 PMCID:PMC10099602

[5] Alwan A, Tavakol Afshari J, Afzaljavan F. Significance of the estrogen hormone and single nucleotide polymorphisms in the progression of breast cancer among female.Arch Razi Inst2022;77:943-58 PMCID:PMC9759246

[6] Kumar T,Thakre S,Velagala VR.Resistance to resilience: understanding post-surgical hormone therapy in breast cancer care.Cureus2023;15:e47869 PMCID:PMC10681032

[7] Boichuk SV.The role of ABC-transporters in homeostasis, cancer pathogenesis and therapy.Usp mol onkol2024;11:8-21

[8] Ramos P.Mechanism-based cancer therapy: resistance to therapy, therapy for resistance.Oncogene2015;34:3617-26

[9] Choi HY.Targeted therapy for cancers: from ongoing clinical trials to FDA-approved drugs.Int J Mol Sci2023;24:13618 PMCID:PMC10487969

[10] Amante RJ,De Silva D.PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer.J Mammary Gland Biol Neoplasia2023;28:13 PMCID:PMC10256672

[11] Scherbakov AM,Kushlinskii NE.Molecular mechanisms of hormone resistance of breast cancer.Bull Exp Biol Med2013;155:384-95

[12] Ariazi EA,Black MA.A new role for ERα: silencing via DNA methylation of basal, stem cell, and EMT genes.Mol Cancer Res2017;15:152-64 PMCID:PMC5308451

[13] Ding X,Lü J.piRNA-823 is involved in cancer stem cell regulation through altering DNA methylation in association with luminal breast cancer.Front Cell Dev Biol2021;9:641052 PMCID:PMC8005588

[14] Li D,Yu S.Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.Cell Signal2020;73:109697

[15] Wang J,Yang J.The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.J Hematol Oncol2019;12:81 PMCID:PMC6657081

[16] Shchegolev YY,Scherbakov AM.Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells.Bioimpacts2023;13:313-21 PMCID:PMC10460766

[17] Andreeva OE,Scherbakov AM.The phenomenon of the cross-resistance of breast cancer to target and hormonal drugs: the role of epigenetic reconstruction.Med Sci Forum2023;20:5.

[18] Sato N,Arai K.The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct-3/4 silencing.Biochem Biophys Res Commun2006;344:845-51

[19] Athanasiadou R,Myant K,Stancheva I.Targeting of de novo DNA methylation throughout the Oct-4 gene regulatory region in differentiating embryonic stem cells.PLoS One2010;5:e9937 PMCID:PMC2848578

[20] Garattini E,Gianni' M,Fratelli M.Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.Oncotarget2016;7:42661-82 PMCID:PMC5173165

[21] Willis S,Dey N.Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs.Meta Gene2015;4:129-41 PMCID:PMC4436509

[22] Hummelke GC.Germ cell nuclear factor is a transcriptional repressor essential for embryonic development.Front Biosci2001;6:D1186-91

[23] Hentschke M,Borgmeyer U.Domains of ERRgamma that mediate homodimerization and interaction with factors stimulating DNA binding.Eur J Biochem2002;269:4086-97

[24] Liu R,Liu G.PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.Cell Death Dis2020;11:797 PMCID:PMC7515865

[25] Gu P,Le Menuet D,Cooney AJ.Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4.Stem Cells2011;29:1041-51

[26] Pacaud R,Oliver L,Tost J.DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NFκB complex in the (de-)methylation of TRAF1.Biochimie2014;104:36-49

[27] Batlle E,Francí C.The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.Nat Cell Biol2000;2:84-9

[28] Wu Y.Snail: More than EMT.Cell Adh Migr2010;4:199-203 PMCID:PMC2900613

[29] Haraguchi M,Miyashita Y.Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins.J Biol Chem2008;283:23514-23 PMCID:PMC3259798

[30] Park M,Ko S,Mo K.Breast cancer metastasis: mechanisms and therapeutic implications.Int J Mol Sci2022;23:6806 PMCID:PMC9224686

[31] Semina SE,Kovalev SV,Krasil'nikov MA.Horizontal transfer of tamoxifen resistance in MCF-7 cell derivates: proteome study.Cancer Invest2017;35:506-18

[32] Iselt M,Hilgard P.The tetrazolium dye assay for rapid in vitro assessment of cytotoxicity.Arzneim-forsch1989;39:747-9.

[33] Scherbakov AM,Khamidullina AI.Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells.Invest New Drugs2023;41:142-52 PMCID:PMC9875769

[34] Ilovaisky AI,Merkulova VM.Secosteroid-quinoline hybrids as new anticancer agents.J Steroid Biochem Mol Biol2023;228:106245

[35] Bindra RS,Meng A.Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.Cancer Res2005;65:11597-604

[36] Dave N,Gutarra S.Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition.J Biol Chem2011;286:12024-32 PMCID:PMC3069405

[37] Reid G,Métivier R.Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling.Molecular cell11(3):695-707

[38] Livak KJ.Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method.Methods2001;25:402-8

[39] Scherbakov AM,Komendantova AS.Steroidal pyrimidines and dihydrotriazines as novel classes of anticancer agents against hormone-dependent breast cancer cells.Front Pharmacol2017;8:979 PMCID:PMC5767602

[40] Scherbakov AM,Shatskaya VA,Gershtein ES.Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?.Breast Cancer Res Treat2006;100:1-11

[41] Sander H,Plouse R,Gomes AV.Ponceau S waste: ponceau S staining for total protein normalization.Anal Biochem2019;575:44-53 PMCID:PMC6954006

[42] Litovchick L.Staining the blot for total protein with ponceau S.Cold Spring Harb Protoc2020;2020:098459

[43] Mruk DD.Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits.Spermatogenesis2011;1:121-2 PMCID:PMC3271654

[44] Taylor SC,Yadav G.A defined methodology for reliable quantification of Western blot data.Mol Biotechnol2013;55:217-26 PMCID:PMC3840294

[45] Li Y,Lu C.The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization.Epigenetics Chromatin2019;12:71 PMCID:PMC6894252

[46] Liu X,Li Y.microRNA-196a-5p inhibits testicular germ cell tumor progression via NR6A1/E-cadherin axis.Cancer Med2020;9:9107-22

[47] Dhasarathy A,Wade PA.The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.Mol Endocrinol2007;21:2907-18 PMCID:PMC2668600

[48] Scherbakov AM,Shatskaya VA.The relationships between snail1 and estrogen receptor signaling in breast cancer cells.J Cell Biochem2012;113:2147-55

[49] Yi Z.Biomarkers of Everolimus sensitivity in hormone receptor-positive breast Cancer.J Breast Cancer2017;20:321-6 PMCID:PMC5743990

[50] Santolla MF.The FGF/FGFR system in breast cancer: oncogenic features and therapeutic perspectives.Cancers2020;12:3029 PMCID:PMC7603197

[51] Clarke R,Dixon JM.Endocrine resistance in breast cancer-an overview and update.Mol Cell Endocrinol2015;418 Pt 3:220-34 PMCID:PMC4684757

[52] Jiang Y,Li S,Tao M.Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer.Ann Transl Med2022;10:366 PMCID:PMC9011257

[53] Lv ZY,Tang HC.Long non-coding RNA (lncRNA) 91H confers tamoxifen resistance in ER + breast cancer cells through Inhibiting mTOR Signaling pathway.Ann clin lab sci2022;52:947-55.

[54] Hentschke M,Borgmeyer U.Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3.J Biol Chem2006;281:33497-504

[55] Xu CG,Ren YQ.Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells.Eur Rev Med Pharmacol Sci2016;20:4362-8.

[56] Hummelke GC.Reciprocal regulation of the mouse protamine genes by the orphan nuclear receptor germ cell nuclear factor and CREMtau.Mol Reprod Dev2004;68:394-407

[57] Wang H,Archer TK,Cooney AJ.GCNF-dependent activation of cyclin D1 expression via repression of Mir302a during ESC differentiation.Stem Cells2014;32:1527-37 PMCID:PMC4091926

[58] Wang Y,Hao Y.NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells.Cell Commun Signal2019;17:77 PMCID:PMC6637573